Interestingly, when MBT-2 (murine transitional carcinoma of the bladder) or L1210R (murine leukemia resistant to the antiproliferative effects of IFN) cells were treated in vitro with IFN-β and then inoculated intracutaneously in C3H/He or Swiss mice, respectively, the inhibition of angiogenesis was noted within 24 hours of tumor cell inoculation, even before their antiproliferative effects on tumor cells [112]. The gene discussed is IFNA1; the disease is neoplasm.